Literature DB >> 10674578

Glycemic control throughout pregnancy and fetal growth in insulin-dependent diabetes.

K Raychaudhuri1, M J Maresh.   

Abstract

OBJECTIVE: To determine the time of growth acceleration in fetuses of insulin-dependent diabetic women who are large for gestational age (LGA) at birth and the relationship between growth acceleration and diabetic control throughout pregnancy.
METHODS: We studied a consecutive sample of 76 women with insulin-dependent diabetes divided by those who delivered LGA or normally grown infants. Fetal abdominal circumference (AC) was measured ultrasonically at regular intervals between 20 and 34 weeks' gestation. Diabetic control was assessed by regular measurement of glycosylated hemoglobin and capillary blood glucose levels.
RESULTS: A significant difference in fetal AC between groups developed between 20 and 24 weeks' gestation, and the LGA group continued to have accelerated fetal growth. Between 18 and 24 weeks glycosylated hemoglobin and capillary blood glucose concentrations were significantly higher in women who delivered LGA infants. After 28 weeks, blood glucose concentrations and glycosylated hemoglobin did not differ significantly between groups. There was a nonsignificant trend toward more vaginal deliveries in the normal group (45% versus 32%).
CONCLUSION: In insulin-dependent diabetic pregnancy, although actual growth acceleration occurred from about 20 weeks' gestation, growth potential of fetuses appeared to be determined by prevailing maternal glucose concentrations before then. Excessive growth continued despite subsequent satisfactory glucose control. If strict blood glucose control is maintained during first and second trimesters, it might reduce the incidence of LGA infants.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674578     DOI: 10.1016/s0029-7844(99)00485-8

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

Review 1.  Assessing Glycemic Control Using CGM for Women with Diabetes in Pregnancy.

Authors:  Grenye O'Malley; Ally Wang; Selassie Ogyaadu; Carol J Levy
Journal:  Curr Diab Rep       Date:  2021-11-04       Impact factor: 4.810

Review 2.  After shoulder dystocia: managing the subsequent pregnancy and delivery.

Authors:  Edith D Gurewitsch; Tara L Johnson; Robert H Allen
Journal:  Semin Perinatol       Date:  2007-06       Impact factor: 3.311

3.  Clinical Experience of Continuous Glucose Monitoring in Pregnancy.

Authors:  Grenye O'Malley; Barak Rosenn; Emily V Nosova; Yogish C Kudva; Sophia Scarpelli Shchur; Camilla Levister; Ravinder Kaur; Jordan E Pinsker; Kristin Castorino; Mei Mei Church; Eyal Dassau; Carol J Levy
Journal:  J Diabetes Sci Technol       Date:  2021-07-03

4.  Assessment of acid-base balance at birth in newborns from diabetic mothers.

Authors:  A Stanescu; S M Stoicescu
Journal:  J Med Life       Date:  2014

5.  Fetal overgrowth in women with type 1 and type 2 diabetes mellitus.

Authors:  Linnea Ladfors; Nael Shaat; Nana Wiberg; Anastasia Katasarou; Kerstin Berntorp; Karl Kristensen
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

Review 6.  The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy.

Authors:  Gernot Desoye; Christopher J Nolan
Journal:  Diabetologia       Date:  2016-03-19       Impact factor: 10.122

Review 7.  Biomarkers for Macrosomia Prediction in Pregnancies Affected by Diabetes.

Authors:  Sofia Nahavandi; Jas-Mine Seah; Alexis Shub; Christine Houlihan; Elif I Ekinci
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-31       Impact factor: 5.555

8.  Associations between capillary glucose during pregnancy and childhood growth to the age of five: a cohort study.

Authors:  Anna Österroos; Linda Lindström; Per Wikman; Anna-Karin Wikström; Inger Sundström Poromaa; Fredrik Ahlsson
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.